← Leaderboards
Manu S Goyal
Washington University
$7,764,823
Attributed
$18,554,141
Total exposure
9
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.5M · FY2017–25$5M$3.8M$2.5M$1.3M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,554,141 · 9
By mechanism
RF1$13,175,660 · 5
R01$5,085,057 · 3
R21$293,424 · 1
Top collaborators
- Andrei G. Vlassenko8 shared
- Jin-Moo Lee3 shared
- Adam Q Bauer2 shared
- Song Hu2 shared
- Carlos Cruchaga1 shared
- Yi Su1 shared
- Yi Wang1 shared
- Dmitriy A Yablonskiy1 shared
Most similar at Washington University
Same institution · by research overlap
- Adam Q Bauer$4,922,550
- Yumirle P Turmelle$1,493,000
- Anne Fagan Niven$12,288,829
- Joel Synes Perlmutter$37,740,662
- David Wang$34,713,611
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposS DiseaseBrainIn VivoImageNerve DegenerationMetabolicOxygenCohortGlucoseMeasurementMetabolismAffectAgingImpaired CognitionMagnetic Resonance ImagingCognitiveResolutionAging BrainAerobic GlycolysisBrain MetabolismAdultBrain RegionCerebrovascular Circulation
Grant awards (13)
White Matter Metabolism in the Context of Aging, White Matter Hyperintensities and Alzheimer's Disease$705,859
R01 · FY2025 · AG
Imaging and Reversibility of Cellular and Network Metabolic Dysfunction in Alzheimer's Disease$700,828
R01 · FY2025 · AG · contact PI
VCID Center Without Walls for Understanding and Leveraging Small Vessel Cerebrovascular Disease Mechanisms in ADRD$4,361,625
RF1 · FY2024 · NS
Brain metabolism during task-evoked and spontaneous activity in aging and Alzheimer's disease$2,289,625
RF1 · FY2023 · AG
Deep-Learning-Augmented Quantitative Gradient Recalled Echo (DLA-qGRE) MRI for in vivo Clinical Evaluation of Brain Microstructural Neurodegeneration in Alzheimer Disease$1,991,759
RF1 · FY2023 · AG
White Matter Metabolism in the Context of Aging, White Matter Hyperintensities and Alzheimer's Disease$2,287,856
RF1 · FY2022 · AG
Imaging and Reversibility of Cellular and Network Metabolic Dysfunction in Alzheimer's Disease$2,244,795
RF1 · FY2022 · AG · contact PI
Aerobic Glycolysis: A Marker of BrainResilience to Aging and Alzheimer's Disease$690,801
R01 · FY2021 · AG
Aerobic Glycolysis: A Marker of BrainResilience to Aging and Alzheimer's Disease$731,109
R01 · FY2020 · AG
Aerobic Glycolysis: A Marker of BrainResilience to Aging and Alzheimer's Disease$745,594
R01 · FY2019 · AG
Aerobic Glycolysis: A Marker of BrainResilience to Aging and Alzheimer's Disease$752,185
R01 · FY2018 · AG
Feasibility of challenge-free QSM based quantitative mapping of cerebral metabolic rate of oxygen$293,424
R21 · FY2018 · EB
Aerobic Glycolysis: A Marker of BrainResilience to Aging and Alzheimer's Disease$758,681
R01 · FY2017 · AG